Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Sep;6(3):612-7.
doi: 10.1159/000343248. Epub 2012 Sep 26.

Successful surgical control of peritoneal dissemination of hepatocellular carcinoma

Affiliations
Case Reports

Successful surgical control of peritoneal dissemination of hepatocellular carcinoma

Norio Yokoigawa et al. Case Rep Gastroenterol. 2012 Sep.

Abstract

Treatment for the peritoneal dissemination of hepatocellular carcinoma (HCC) has not yet been established. We report a patient with HCC associated with disseminated intra-abdominal tumor. A 74-year-old man was admitted to our hospital. Computed tomography showed a 3 × 3 cm mass in the left hepatic lobe and a giant mass between the stomach and spleen. At laparotomy, the tumor was seen in the medial segment and evaginated to the diaphragm. There was a tumor between the stomach and spleen, confirmed as a 5 × 5 cm tumor evaginated from the left diaphragm, and a 7 × 7 cm tumor adhesive to the spleen. These two tumors were not continuous and were separated. Furthermore, we confirmed a 10 × 10 cm tumor in the pelvic cavity. We performed partial hepatectomy, resection of the tumor evaginated from the diaphragm, resection of the tumor of the spleen and tail of pancreas, and resection of the tumor in the pelvic cavity. Histopathologically, all resected tumors were confirmed to be well-differentiated HCC. HCC rarely disseminates intraperitoneally. It is considered that the peritoneal dissemination of HCC occurred from poorly differentiated or undifferentiated type. Then this report is a rare case. Although surgical treatment of peritoneal dissemination of HCC is not curative, surgery may improve survival and provide good quality of life in selected cases.

Keywords: Hepatocellular carcinoma; Peritoneal dissemination; Surgical control.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Ultrasonography showed a well-defined 3.5 × 2.6 cm high-echoic mass in the medial segment of the liver.
Fig. 2
Fig. 2
Enhanced computed tomography revealed a low-density area in the medial segment of the liver (a; arrow) and a giant mass continuing from the diaphragm to the left kidney between the stomach and spleen (a, b; arrowhead).
Fig. 3
Fig. 3
a–d Surgical specimens. All specimens were solid and of well-defined shape. a Tumor of the liver. b Tumor of the diaphragm. c Tumor of the omentum. d Tumor of the hilum of the spleen. e–h Histopathologic examination of all resected specimens revealed well-differentiated HCC and steatosis (hematoxylin and eosin, ×200). e Tumor of the liver. f Tumor of the diaphragm. g Tumor of the omentum. h Tumor of the hilum of the spleen.

References

    1. Uenishi T, Kubo S, Hirohashi K, et al. Successful surgical control for hepatocellular carcinoma disseminated to the peritoneum: a case report. Hepatogastroenterology. 2002;49:532–534. - PubMed
    1. Ryu JK, Lee SB, Kim KH, Yoh KT. Surgical treatment in a patient with multiple implanted intraperitoneal metastases after resection of ruptured large hepatocellular carcinoma. Hepatogastroenterology. 2004;51:239–242. - PubMed
    1. Takahashi H, Konishi M, Nakagohri T, et al. Aggressive multimodal treatment for peritoneal dissemination and needle tract implantation of hepatocellular carcinoma: a case report. Jpn J Clin Oncol. 2004;34:551–555. - PubMed
    1. Kaido T, Arii S, Shiota M, Imamura M. Repeated resection for extrahepatic recurrences after hepatectomy for ruptured hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2004;11:149–152. - PubMed
    1. Miyake Y, Iwasaki Y, Shiraha H, Sakaguchi K, Shiratori Y. Peritoneal dissemination of hepatocellular carcinoma treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil. Intern Med. 2007;46:565–569. - PubMed

Publication types